{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:50:57Z","timestamp":1789861857596,"version":"4.0.1"},"reference-count":54,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Large granular lymphocyte (LGL) leukemia, or LGLL, is characterized by increased numbers of circulating clonal LGL cells in association with neutropenia, anemia, rheumatoid arthritis, and pulmonary artery hypertension (PAH). Emerging evidence suggests that LGLL cells with a CD8+CD28null phenotype induce these clinical manifestations through direct destruction of normal tissue. Compared with CD8+CD28null T cells from healthy controls, CD8+CD28null T cells from LGLL patients have acquired the ability to directly lyse pulmonary artery endothelial cells and human synovial cells. Here, we show that LGLL cells from patients possess enhanced cytotoxic characteristics and express elevated levels of activating natural killer receptors as well as their signaling partners, DAP10 and DAP12. Moreover, downstream targets of DAP10 and DAP12 are constitutively activated in LGLL cells, and expression of dominant-negative DAP10 and DAP12 dramatically reduces their lytic capacity. These are the first results to show that activating NKR-ligand interactions play a critical role in initiating the DAP10 and DAP12 signaling events that lead to enhanced lytic potential of LGLL cells. Results shown suggest that inhibitors of DAP10 and DAP12 or other proteins involved in this signaling pathway will be attractive therapeutic targets for the treatment of LGLL and other autoimmune diseases and syndromes.<\/jats:p>","DOI":"10.1182\/blood-2008-07-168245","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T21:31:42Z","timestamp":1229376702000},"page":"3226-3234","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":41,"title":["A critical role for DAP10 and DAP12 in CD8+ T cell\u2013mediated tissue damage in large granular lymphocyte leukemia"],"prefix":"10.1182","volume":"113","author":[{"given":"Xianghong","family":"Chen","sequence":"first","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Bai","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomir","family":"Sokol","sequence":"additional","affiliation":[{"name":"Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Ren","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Painter","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Sallman","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Ann","family":"Chen","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Yoder","sequence":"additional","affiliation":[{"name":"Department of Molecular Biomedical Sciences and Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, Raleigh;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Y.","family":"Djeu","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Loughran","sequence":"additional","affiliation":[{"name":"Penn State Cancer Institute, Penn State College of Medicine, Hershey; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearlie K.","family":"Epling-Burnette","sequence":"additional","affiliation":[{"name":"Immunology Program and"},{"name":"Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"},{"name":"James A. Haley VA Hospital, Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wei","sequence":"additional","affiliation":[{"name":"Immunology Program and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713540046000_B1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1182\/blood.V69.6.1786.1786","article-title":"Clinical features in large granular lymphocytic leukemia [letter].","volume":"69","author":"Loughran","year":"1987","journal-title":"Blood"},{"key":"2019111713540046000_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V82.1.1.bloodjournal8211","article-title":"Clonal diseases of large granular lymphocytes.","volume":"82","author":"Loughran","year":"1993","journal-title":"Blood"},{"key":"2019111713540046000_B3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005792-198709000-00005","article-title":"Large granular lymphocyte leukemia: report of 38 cases and review of the literature.","volume":"66","author":"Loughran","year":"1987","journal-title":"Medicine (Baltimore)"},{"key":"2019111713540046000_B4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","article-title":"Large granular lymphocyte leukemia.","volume":"11","author":"Sokol","year":"2006","journal-title":"Oncologist"},{"key":"2019111713540046000_B5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2141.2000.01934.x","article-title":"Clinicopathological features of aggressive large granular lymphocyte leukaemia resemble Fas ligand transgenic mice.","volume":"108","author":"Lamy","year":"2000","journal-title":"Br J Haematol"},{"key":"2019111713540046000_B6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1054\/blre.1999.0118","article-title":"Current concepts: large granular lymphocyte leukemia.","volume":"13","author":"Lamy","year":"1999","journal-title":"Blood Rev"},{"key":"2019111713540046000_B7","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood.V81.9.2363.2363","article-title":"Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.","volume":"81","author":"Nash","year":"1993","journal-title":"Blood"},{"key":"2019111713540046000_B8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1378\/chest.112.2.551","article-title":"Primary pulmonary hypertension in a patient with CD8\/T-cell large granulocyte leukemia: amelioration by cladribine therapy.","volume":"112","author":"Rossoff","year":"1997","journal-title":"Chest"},{"key":"2019111713540046000_B9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/hc0502.103348","article-title":"T-cell-mediated lysis of endothelial cells in acute coronary syndromes.","volume":"105","author":"Nakajima","year":"2002","journal-title":"Circulation"},{"key":"2019111713540046000_B10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1097-0142(19890101)63:1<90::AID-CNCR2820630115>3.0.CO;2-F","article-title":"Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes\/natural killer cells.","volume":"63","author":"Bassan","year":"1989","journal-title":"Cancer"},{"key":"2019111713540046000_B11","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand.","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"key":"2019111713540046000_B12","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/blood.V100.4.1449.h81602001449_1449_1453","article-title":"Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia.","volume":"100","author":"Liu","year":"2002","journal-title":"Blood"},{"key":"2019111713540046000_B13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"Reprogramming of CTLs into natural killer-like cells in celiac disease.","volume":"203","author":"Meresse","year":"2006","journal-title":"J Exp Med"},{"key":"2019111713540046000_B14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.RES.0000082333.58263.58","article-title":"De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes.","volume":"93","author":"Nakajima","year":"2003","journal-title":"Circ Res"},{"key":"2019111713540046000_B15","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000220649.10013.5c","article-title":"T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome.","volume":"98","author":"Pryshchep","year":"2006","journal-title":"Circ Res"},{"key":"2019111713540046000_B16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1084\/jem.20051062","article-title":"TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.","volume":"203","author":"Sato","year":"2006","journal-title":"J Exp Med"},{"key":"2019111713540046000_B17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0037-1963(03)00134-3","article-title":"Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes.","volume":"40","author":"Zambello","year":"2003","journal-title":"Semin Hematol"},{"key":"2019111713540046000_B18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition.","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"2019111713540046000_B19","first-page":"636","article-title":"A view to a kill: signals triggering cytotoxicity.","volume":"8","author":"Djeu","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2019111713540046000_B20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/338383b0","article-title":"Antigen receptor tail clue.","volume":"338","author":"Reth","year":"1989","journal-title":"Nature"},{"key":"2019111713540046000_B21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/80859","article-title":"Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells.","volume":"1","author":"Jiang","year":"2000","journal-title":"Nat Immunol"},{"key":"2019111713540046000_B22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: a national prospective study.","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"2019111713540046000_B23","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1038\/sj.onc.1208122","article-title":"ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL).","volume":"23","author":"Epling-Burnette","year":"2004","journal-title":"Oncogene"},{"key":"2019111713540046000_B24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.187.11.1753","article-title":"Control of lytic function by mitogen-activated protein kinase\/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2.","volume":"187","author":"Wei","year":"1998","journal-title":"J Exp Med"},{"key":"2019111713540046000_B25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00251-007-0250-6","article-title":"The zebrafish activating immune receptor Nitr9 signals via Dap12.","volume":"59","author":"Wei","year":"2007","journal-title":"Immunogenetics"},{"key":"2019111713540046000_B26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.0105-2896.2005.00262.x","article-title":"Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging.","volume":"205","author":"Fann","year":"2005","journal-title":"Immunol Rev"},{"key":"2019111713540046000_B27","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.4049\/jimmunol.165.7.3811","article-title":"Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway [In Process Citation].","volume":"165","author":"Wei","year":"2000","journal-title":"J Immunol"},{"key":"2019111713540046000_B28","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.4049\/jimmunol.168.7.3155","article-title":"Syk regulation of phosphoinositide 3-kinase-dependent NK cell function.","volume":"168","author":"Jiang","year":"2002","journal-title":"J Immunol"},{"key":"2019111713540046000_B29","doi-asserted-by":"crossref","first-page":"9654","DOI":"10.1128\/JVI.75.20.9654-9664.2001","article-title":"Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site.","volume":"75","author":"Lamikanra","year":"2001","journal-title":"J Virol"},{"key":"2019111713540046000_B30","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1053\/j.gastro.2007.03.025","article-title":"CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.","volume":"132","author":"Allez","year":"2007","journal-title":"Gastroenterology"},{"key":"2019111713540046000_B31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/ar1034","article-title":"Natural killer cells and autoimmunity.","volume":"6","author":"French","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"2019111713540046000_B32","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1196\/annals.1361.076","article-title":"Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea.","volume":"1051","author":"Dyugovskaya","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"2019111713540046000_B33","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00262-005-0682-5","article-title":"CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype.","volume":"54","author":"Casado","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"2019111713540046000_B34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00262-006-0141-y","article-title":"Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.","volume":"56","author":"Solana","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"2019111713540046000_B35","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.0.CO;2-9","article-title":"CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.","volume":"29","author":"Speiser","year":"1999","journal-title":"Eur J Immunol"},{"key":"2019111713540046000_B36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.mad.2007.05.001","article-title":"Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes.","volume":"128","author":"Xie","year":"2007","journal-title":"Mech Ageing Dev"},{"key":"2019111713540046000_B37","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.176.3.1490","article-title":"IL-21 down-regulates NKG2D\/DAP10 expression on human NK and CD8+ T cells.","volume":"176","author":"Burgess","year":"2006","journal-title":"J Immunol"},{"key":"2019111713540046000_B38","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2005-10-4077","article-title":"Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.","volume":"107","author":"Orabona","year":"2006","journal-title":"Blood"},{"key":"2019111713540046000_B39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1172\/JCI0214843","article-title":"ITAMs versus ITIMs: striking a balance during cell regulation.","volume":"109","author":"Billadeau","year":"2002","journal-title":"J Clin Invest"},{"key":"2019111713540046000_B40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.194.4.455","article-title":"Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail.","volume":"194","author":"Kraus","year":"2001","journal-title":"J Exp Med"},{"key":"2019111713540046000_B41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.190.11.1627","article-title":"Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation.","volume":"190","author":"Kersh","year":"1999","journal-title":"J Exp Med"},{"key":"2019111713540046000_B42","doi-asserted-by":"crossref","first-page":"34115","DOI":"10.1074\/jbc.273.51.34115","article-title":"Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)\/DAP-12.","volume":"273","author":"Tomasello","year":"1998","journal-title":"J Biol Chem"},{"key":"2019111713540046000_B43","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.2047875","article-title":"Vaccinia virus: a tool for research and vaccine development.","volume":"252","author":"Moss","year":"1991","journal-title":"Science"},{"key":"2019111713540046000_B44","doi-asserted-by":"crossref","first-page":"15706","DOI":"10.1073\/pnas.0405242101","article-title":"Resolution of the novel immune-type receptor gene cluster in zebrafish.","volume":"101","author":"Yoder","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713540046000_B45","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood-2001-12-0180","article-title":"Human neutrophils utilize a Rac\/Cdc42-dependent MAPK pathway to direct intracellular granule mobilization toward ingested microbial pathogens.","volume":"101","author":"Zhong","year":"2003","journal-title":"Blood"},{"key":"2019111713540046000_B46","first-page":"529","article-title":"Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia.","volume":"26","author":"Kothapalli","year":"2005","journal-title":"Int J Oncol"},{"key":"2019111713540046000_B47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond.","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"2019111713540046000_B48","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1521-4141(200209)32:9<2653::AID-IMMU2653>3.0.CO;2-V","article-title":"Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP\/DAP12-transgenic mice.","volume":"32","author":"Lucas","year":"2002","journal-title":"Eur J Immunol"},{"key":"2019111713540046000_B49","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.4049\/jimmunol.177.8.4981","article-title":"DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections.","volume":"177","author":"French","year":"2006","journal-title":"J Immunol"},{"key":"2019111713540046000_B50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0037-1963(03)00135-5","article-title":"Survival signals in leukemic large granular lymphocytes.","volume":"40","author":"Epling-Burnette","year":"2003","journal-title":"Semin Hematol"},{"key":"2019111713540046000_B51","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.","volume":"100","author":"Groh","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713540046000_B52","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1073\/pnas.0702975104","article-title":"NRAS mutation causes a human autoimmune lymphoproliferative syndrome.","volume":"104","author":"Oliveira","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713540046000_B53","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.4049\/jimmunol.173.6.3725","article-title":"Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms.","volume":"173","author":"Snyder","year":"2004","journal-title":"J Immunol"},{"key":"2019111713540046000_B54","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.165.2.1138","article-title":"Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis.","volume":"165","author":"Namekawa","year":"2000","journal-title":"J Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/14\/3226\/1304833\/zh801409003226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/14\/3226\/1304833\/zh801409003226.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T13:54:19Z","timestamp":1573998859000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/14\/3226\/24805\/A-critical-role-for-DAP10-and-DAP12-in-CD8-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,2]]},"references-count":54,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2009,4,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-07-168245","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,2]]}}}